CVS Share Price | CVS Health Corp. Stock Analysis & Recommendation

Q: What does CVS Health Corp. do?

Overview:CVS Health Corporation is an integrated pharmacy healthcare company operating in the Retailing industry, with a market capitalization in the large-cap bracket.Financial Snapshot:Most recent Net Sales: 94,609 Million (Quarterly Results - Mar 2025)Most recent Net Profit: 1,782 Million (Quarterly Results - Mar 2025)Market-cap: USD 113,182.13 Million (Large Cap)Key Metrics:P/E: 17.00Dividend Yield: 227.13%Debt Equity: 0.70Return on Equity: 8.14%Price to Book: 1.47Contact Details:Address: 1 Cvs Dr, WOONSOCKET RI: 02895-6146Tel: 1 401 7651500Website: https://cvshealth.com/

Q: Is CVS Health Corp. technically bullish or bearish?

As of 18 August 2025, the technical trend for CVS Health Corp. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. The Bollinger Bands show a bullish signal on the monthly timeframe. However, the RSI does not provide any clear signals on both weekly and monthly timeframes. In terms of performance, CVS has outperformed the S&P 500 year-to-date with a return of 65.78% compared to the S&P 500's 12.22%. Over the past year, CVS returned 27.39% against the S&P 500's 17.14%. Overall, the current technical stance is bullish, supported by multiple indicators, though some metrics show only mild bullishness.

Q: Is CVS Health Corp. overvalued or undervalued?

As of 17 October 2025, CVS Health Corp. has moved from very expensive to expensive, indicating a slight improvement in its valuation stance but still suggesting it is overvalued. The company is currently assessed as overvalued based on its P/E ratio of 17, which is below its peer average of approximately 19.83, and an EV to EBITDA ratio of 9.97, which also indicates a premium compared to its peers. Additionally, the Price to Book Value stands at 1.39, further supporting the notion of overvaluation.In comparison to its peers, CVS Health Corp. exhibits a lower P/E ratio than the industry average, while its EV to EBITDA is slightly more favorable than some competitors, suggesting it may not be as attractive as it appears. Notably, the company's recent stock performance has outpaced the S&P 500, with a year-to-date return of 83.83% compared to the S&P 500's 13.30%, but this strong performance is overshadowed by a three-year return of -9.21% versus the S&P 500's 81.19%, highlighting potential volatility and risk.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

18.75 M

Shareholding (Dec 2025)

FII

16.63%

Held by 542 FIIs

DII

41.22%

Held by 163 DIIs

Promoter

0.11%

How big is CVS Health Corp.?

22-Jun-2025

As of Jun 18, CVS Health Corp. has a market capitalization of $113.18 billion. For the latest 4 quarters, net sales totaled $378.85 billion, with a net profit of $5.24 billion.

View full answer

What does CVS Health Corp. do?

22-Jun-2025

CVS Health Corporation is an integrated pharmacy healthcare company with a market cap of approximately $113.18 billion, reporting net sales of $94.61 billion and a net profit of $1.78 billion as of March 2025. Key metrics include a P/E ratio of 17.00 and a dividend yield of 227.13%.

View full answer

Who are in the management team of CVS Health Corp.?

22-Jun-2025

As of March 2022, the management team of CVS Health Corp. includes Independent Chairman David Dorman, President and CEO Larry Merlo, and several Independent Directors: Fernando Aguirre, C. David Brown, Alecia DeCoudreaux, Nancy-Ann DeParle, and Roger Farah. They oversee the company's strategic direction and operations.

View full answer

Is CVS Health Corp. technically bullish or bearish?

20-Sep-2025

As of August 18, 2025, CVS Health Corp. has a bullish technical trend, supported by positive MACD and moving averages, while outperforming the S&P 500 year-to-date with a return of 65.78%.

View full answer

Is CVS Health Corp. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, CVS Health Corp. is considered overvalued with a P/E ratio of 17 compared to the industry average of 19.83, despite a strong year-to-date stock performance of 83.83%, but it has a three-year return of -9.21%, indicating potential volatility and risk.

View full answer

Compare CVS Health Corp. with Similar Stocks

Rite Aid Corp.China Jo-Jo Drugstores, Inc.Quest Diagnostics, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Healthy long term growth as Net Sales has grown by an annual rate of 7.94%

Flat results in Jun 25

With ROCE of 8.83%, it has a very expensive valuation with a 1.23 Enterprise value to Capital Employed

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Retailing

Market cap

USD 128,489 Million (Large Cap)

P/E

14.00

Industry P/E

Dividend Yield

2.61%

Debt Equity

0.72

Return on Equity

12.13%

Price to Book

1.71

Revenue and Profits:

Net Sales:

105,678 Million

(Quarterly Results - Dec 2025)

Net Profit:

2,923 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-8.11%

6 Months

-3.95%

1 Year

5.79%

2 Years

-7.85%

3 Years

-3.89%

4 Years

-33.38%

5 Years

-4.03%

CVS Health Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

8.40%

EBIT Growth (5y)

-2.25%

EBIT to Interest (avg)

5.45

Debt to EBITDA (avg)

2.69

Net Debt to Equity (avg)

0.70

Sales to Capital Employed (avg)

2.64

Tax Ratio

27.01%

Dividend Payout Ratio

191.23%

Pledged Shares

Institutional Holding

92.24%

ROCE (avg)

11.63%

ROE (avg)

12.35%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.71

EV to EBIT

14.44

EV to EBITDA

10.59

EV to Capital Employed

1.41

EV to Sales

0.45

PEG Ratio

0.20

Dividend Yield

2.61%

ROCE (Latest)

9.77%

ROE (Latest)

12.13%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 229 Schemes (42.03%)

Foreign Institutions

Held by 542 Foreign Institutions (16.63%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 8.38% vs 3.77% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 80.10% vs -20.71% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "105,678.00",
          "val2": "97,504.00",
          "chgp": "8.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,464.00",
          "val2": "3,359.00",
          "chgp": "3.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "769.00",
          "val2": "754.00",
          "chgp": "1.99%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-220.00",
          "val2": "441.00",
          "chgp": "-149.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,923.00",
          "val2": "1,623.00",
          "chgp": "80.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.90%",
          "val2": "22.70%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 7.89% vs 4.02% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -62.32% vs -45.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "402,111.00",
          "val2": "372,692.00",
          "chgp": "7.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17,073.00",
          "val2": "14,518.00",
          "chgp": "17.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3,096.00",
          "val2": "2,938.00",
          "chgp": "5.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7,475.00",
          "val2": "-1,031.00",
          "chgp": "-625.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,728.00",
          "val2": "4,586.00",
          "chgp": "-62.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.00%",
          "val2": "26.60%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

105,678.00

97,504.00

8.38%

Operating Profit (PBDIT) excl Other Income

3,464.00

3,359.00

3.13%

Interest

769.00

754.00

1.99%

Exceptional Items

-220.00

441.00

-149.89%

Consolidate Net Profit

2,923.00

1,623.00

80.10%

Operating Profit Margin (Excl OI)

21.90%

22.70%

-0.08%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 8.38% vs 3.77% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 80.10% vs -20.71% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

402,111.00

372,692.00

7.89%

Operating Profit (PBDIT) excl Other Income

17,073.00

14,518.00

17.60%

Interest

3,096.00

2,938.00

5.38%

Exceptional Items

-7,475.00

-1,031.00

-625.02%

Consolidate Net Profit

1,728.00

4,586.00

-62.32%

Operating Profit Margin (Excl OI)

31.00%

26.60%

0.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 7.89% vs 4.02% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -62.32% vs -45.20% in Dec 2024

All Annual Results

Company CV

About CVS Health Corp.

CVS Health Corp.

Retailing

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Company Coordinates

Company Details

1 Cvs Dr , WOONSOCKET RI : 02895-6146

Tel: 1 401 7651500

https://cvshealth.com/

Registrar Details